Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Multiprofessional Advance Care Planning and Shared Decision Making for End of Life Care (MAPS)

3. juni 2016 oppdatert av: University of Zurich

Multiprofessional Advance Care Planning and Shared Decision-making for End of Life Care MAPS Trial

Multiprofessional Advance Care Planning and shared decision making for end of live care for terminal patients and their relatives.

The aim of this study is to develop, implement and test a complex intervention for improving patients' preparation for and participation in end of life decisions. In cooperation with local, national and international partners, the investigators will focus on strategies to enhance advance care planning and shared decision making on end of life issues, and documentation and transferability of end of life decisions across health care settings in coordinated approach involving patients, their families and care givers (in and out of hospital).

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

115

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Sveits
    • ZH
      • Zurich, ZH, Sveits, 8091
        • University Hospital Zurich, Clinical Ethics

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion criteria: -patients in which the treating physician on the ward would not be surprised if the patient died during the next year (surprise question of Weissman et al 2011)

  • male and female patients above 18 years of age
  • signed informed consent after being informed
  • patients able to appoint a surrogate decision maker (SM) and/or responsible physician to be contacted after discharge

Exclusion criteria: -patients not capable of speaking german

  • patients having no responsible physician to be contacted after discharge and no relative/future surrogate decision maker (SM)
  • inhouse patients being discharged within the next 2 days or ambulatory patients not regularly coming to the wards (at least every two month)
  • patients assessed by their physician to be in obvious denial of their situation (illness/prognosis)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Trippel

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Control Group
A routine care discharge planning with the social service
Annen: Control Group
A routine care discharge planning with the social service
Eksperimentell: Advance Care Planning ACP

Patient get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators.

--------------------------------------------------------------------------------
Annen: Advance Care Planning ACP
Patient of the intervention group get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
end of life wish on resuscitation known (if alive) or fulfilled(if dead) after 6 month by responsible physician and/or surrogate decision maker (SM)
Tidsramme: during 2 weeks six months after discharge
during 2 weeks six months after discharge

Sekundære resultatmål

Resultatmål
Tidsramme
end of live decisions on last place of care, antibiotics for pneumonia, feeding tube, intravenous fluids, dialysis, intubation and sedation,
Tidsramme: during 2 weeks six months after discharge
during 2 weeks six months after discharge
decisional conflict scale ("DCS"), O Connor et al 1995
Tidsramme: at discharge and during 2 Weeks six months after discharge
at discharge and during 2 Weeks six months after discharge
Satisfaction with information and care, (see Detering et al 2010)
Tidsramme: at discharge
at discharge
Hospital Anxiety and Depression scale ("HADS")
Tidsramme: discharge and during 2 weeks six months after discharge
discharge and during 2 weeks six months after discharge
Having an Advance directive
Tidsramme: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
Having an appointed surrogate decision maker
Tidsramme: at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge
at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge
Any hospital stay
Tidsramme: during 2 weeks three months after discharge and during 2 weeks six months after discharge
during 2 weeks three months after discharge and during 2 weeks six months after discharge
Decisions regarding end of life issues already having been made/taken place
Tidsramme: during 2 weeks six months after discharge
during 2 weeks six months after discharge
open question on important medical decisions being made
Tidsramme: during 2 weeks three months after discharge
during 2 weeks three months after discharge
Treatment against patients wishes
Tidsramme: during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death
during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death
Distress of Patients or relatives because of content of the consultation
Tidsramme: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge
at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University of Zurich

Etterforskere

  • Hovedetterforsker: Tanja Krones, MD, University Hospital Zurich, Clinical Ethics

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. juli 2013

Primær fullføring (Faktiske)

1. april 2015

Studiet fullført (Faktiske)

1. august 2015

Datoer for studieregistrering

Først innsendt

26. november 2012

Først innsendt som oppfylte QC-kriteriene

30. juli 2013

Først lagt ut (Anslag)

2. august 2013

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

6. juni 2016

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. juni 2016

Sist bekreftet

1. juni 2016

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • MAPS Trial

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Palliative pasienter

Kliniske studier på Control Group

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Gabon

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

3
Abonnere